Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells.
- 1 May 1995
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 48 (5) , 482-487
- https://doi.org/10.1136/jcp.48.5.482
Abstract
To investigate the effects of interleukin (IL) 1, 2, 4, and 5 on the proliferation and survival of peripheral blood B cells from patients with B chronic lymphocytic leukaemia (B-CLL) and compare them with the effects on normal peripheral blood B cells. The proliferation and survival of pokeweed mitogen (PWM) activated B cells from B-CLL (n = 12) and normal peripheral blood (n = 5) were studied in vitro in response to IL-1, IL-2 IL-4, and IL-5. Survival of cells in cultures with or without added interleukins was studied by microscopic examination of cells and DNA agarose gel electrophoresis. Proliferation was observed in both B-CLL and normal peripheral blood cells on culture with IL-2 alone and also in some, but not all, B-CLL and normal peripheral blood cells with IL-1 and IL-4. However, there was greater variability in B-CLL cell responses than in normal peripheral blood cells. Il-5 did not affect normal peripheral blood cell proliferation but it increased proliferation in two B-CLL cases. Synergistic effects of these cytokines were not detected. IL-4 inhibited normal peripheral blood and B-CLL cell proliferation after the addition of IL-2. Inhibition of B-CLL cell responses to IL-2 was also observed with IL-5 and Il-1. Survival of B-CLL cells in cultures was enhanced with IL-4 not by an increase in proliferation but by reduced apoptosis. No such effect was seen in normal peripheral blood cells. IL-2 had a less noticeable antiapoptotic effect; IL-5 enhanced apoptosis in B-CLL cells. B-CLL and normal peripheral blood cells proliferated equally well in response to IL-2. IL-4 had a much lower effect on B-CLL cell proliferation, but had noticeable antiapoptotic activity. IL-5 enhanced cell death by apoptosis.Keywords
This publication has 37 references indexed in Scilit:
- Interleukin‐4 inhibits apoptotic cell death and loss of the bcl‐2 protein in B‐chronic lymphocytic leukaemia cells in vitroBritish Journal of Haematology, 1993
- Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.The Journal of Experimental Medicine, 1992
- Apoptosis: Final control point in cell biologyTrends in Cell Biology, 1992
- Cellular signalling in programmed cell death (apoptosis)Immunology Today, 1990
- CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSESAnnual Review of Biochemistry, 1990
- Erythropoietin Retards DNA Breakdown and Prevents Programmed Death in Erythroid Progenitor CellsScience, 1990
- Protein kinase-C involvement in thymocyte apoptosis induced by hydrocortisoneCellular Immunology, 1990
- Proliferation of B Cells from Chronic Lymphocytic Leukemia Is Selectively Promoted by B Cell Growth FactorActa Haematologica, 1989
- Heterogenity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: Relationship to B-cell-derived lymphokinesCellular Immunology, 1986
- Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cellsNature, 1984